Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Neuromolecular Med
2012 Dec 01;144:328-37. doi: 10.1007/s12017-012-8190-1.
Show Gene links
Show Anatomy links
Dominantly inherited myotonia congenita resulting from a mutation that increases open probability of the muscle chloride channel CLC-1.
Richman DP
,
Yu Y
,
Lee TT
,
Tseng PY
,
Yu WP
,
Maselli RA
,
Tang CY
,
Chen TY
.
???displayArticle.abstract???
Myotonia congenita-inducing mutations in the muscle chloride channel CLC-1 normally result in reduced open probability (P (o)) of this channel. One well-accepted mechanism of the dominant inheritance of this disease involves a dominant-negative effect of the mutation on the function of the common-gate of this homodimeric, double-barreled molecule. We report here a family with myotonia congenita characterized by muscle stiffness and clinical and electrophysiologic myotonic phenomena transmitted in an autosomal dominant pattern. DNA sequencing of DMPK and ZNF9 genes for myotonic muscular dystrophy types I and II was normal, whereas sequencing of CLC-1 encoding gene, CLCN1, identified a single heterozygous missense mutation, G233S. Patch-clamp analyses of this mutant CLC-1 channel in Xenopus oocytes revealed an increased P (o) of the channel's fast-gate, from ~0.4 in the wild type to >0.9 in the mutant at -90 mV. In contrast, the mutant exhibits a minimal effect on the P (o) of the common-gate. These results are consistent with the structural prediction that the mutation site is adjacent to the fast-gate of the channel. Overall, the mutant could lead to a significantly reduced dynamic response of CLC-1 to membrane depolarization, from a fivefold increase in chloride conductance in the wild type to a twofold increase in the mutant-this might result in slower membrane repolarization during an action potential. Since expression levels of the mutant and wild-type subunits in artificial model cell systems were unable to explain the disease symptoms, the mechanism leading to dominant inheritance in this family remains to be determined.
Chen,
Structure and function of clc channels.
2005, Pubmed
Chen,
Structure and function of clc channels.
2005,
Pubmed
Colding-Jørgensen,
Phenotypic variability in myotonia congenita.
2005,
Pubmed
Duffield,
Involvement of helices at the dimer interface in ClC-1 common gating.
2003,
Pubmed
Dunø,
Difference in allelic expression of the CLCN1 gene and the possible influence on the myotonia congenita phenotype.
2004,
Pubmed
Dutzler,
The structural basis of ClC chloride channel function.
2004,
Pubmed
Dutzler,
The ClC family of chloride channels and transporters.
2006,
Pubmed
Fahlke,
Pore-forming segments in voltage-gated chloride channels.
1997,
Pubmed
Furman,
The pathophysiology of myotonia produced by aromatic carboxylic acids.
1978,
Pubmed
Gao,
Novel chloride channel gene mutations in two unrelated Chinese families with myotonia congenita.
2010,
Pubmed
Grunnet,
Characterization of two new dominant ClC-1 channel mutations associated with myotonia.
2003,
Pubmed
,
Xenbase
Heatwole,
The nondystrophic myotonias.
2007,
Pubmed
Jentsch,
CLC chloride channels and transporters: from genes to protein structure, pathology and physiology.
2008,
Pubmed
Koty,
Myotonia and the muscle chloride channel: dominant mutations show variable penetrance and founder effect.
1996,
Pubmed
Kubisch,
ClC-1 chloride channel mutations in myotonia congenita: variable penetrance of mutations shifting the voltage dependence.
1998,
Pubmed
,
Xenbase
Kumar,
A novel CLCN1 mutation (G1652A) causing a mild phenotype of thomsen disease.
2010,
Pubmed
Li,
Hyperphosphorylation as a defense mechanism to reduce TDP-43 aggregation.
2011,
Pubmed
Lin,
Functional characterization of CLCN1 mutations in Taiwanese patients with myotonia congenita via heterologous expression.
2006,
Pubmed
,
Xenbase
Lossin,
Myotonia congenita.
2008,
Pubmed
Lyons,
Novel CLCN1 mutation in carbamazepine-responsive myotonia congenita.
2010,
Pubmed
Macías,
Myotonia-related mutations in the distal C-terminus of ClC-1 and ClC-0 chloride channels affect the structure of a poly-proline helix.
2007,
Pubmed
,
Xenbase
Mailänder,
Novel muscle chloride channel mutations and their effects on heterozygous carriers.
1996,
Pubmed
Moon,
Novel CLCN1 mutations and clinical features of Korean patients with myotonia congenita.
2009,
Pubmed
Morales,
Clinical and molecular diagnosis of a Costa Rican family with autosomal recessive myotonia congenita (Becker disease) carrying a new mutation in the CLCN1 gene.
2008,
Pubmed
Papponen,
F413C and A531V but not R894X myotonia congenita mutations cause defective endoplasmic reticulum export of the muscle-specific chloride channel CLC-1.
2008,
Pubmed
Pusch,
Myotonia caused by mutations in the muscle chloride channel gene CLCN1.
2002,
Pubmed
Pusch,
Mutations in dominant human myotonia congenita drastically alter the voltage dependence of the CIC-1 chloride channel.
1995,
Pubmed
Raj,
Variability in gene expression underlies incomplete penetrance.
2010,
Pubmed
Ryan,
A novel alteration of muscle chloride channel gating in myotonia levior.
2002,
Pubmed
Saviane,
The muscle chloride channel ClC-1 has a double-barreled appearance that is differentially affected in dominant and recessive myotonia.
1999,
Pubmed
,
Xenbase
Shalata,
Myotonia congenita in a large consanguineous Arab family: insight into the clinical spectrum of carriers and double heterozygotes of a novel mutation in the chloride channel CLCN1 gene.
2010,
Pubmed
Simpson,
Characterization of three myotonia-associated mutations of the CLCN1 chloride channel gene via heterologous expression.
2004,
Pubmed
,
Xenbase
Tseng,
Cytoplasmic ATP inhibition of CLC-1 is enhanced by low pH.
2007,
Pubmed
,
Xenbase
Tseng,
Binding of ATP to the CBS domains in the C-terminal region of CLC-1.
2011,
Pubmed
,
Xenbase
Warnstedt,
The myotonia congenita mutation A331T confers a novel hyperpolarization-activated gate to the muscle chloride channel ClC-1.
2002,
Pubmed
Wu,
Novel CLCN1 mutations with unique clinical and electrophysiological consequences.
2002,
Pubmed
Zhang,
Mutations in the human skeletal muscle chloride channel gene (CLCN1) associated with dominant and recessive myotonia congenita.
1996,
Pubmed
Zhang,
ATP inhibition of CLC-1 is controlled by oxidation and reduction.
2008,
Pubmed
,
Xenbase
